KR102555447B1 - Rna 전사물 변이체의 정량분석을 위한 방법 및 생성물 - Google Patents
Rna 전사물 변이체의 정량분석을 위한 방법 및 생성물 Download PDFInfo
- Publication number
- KR102555447B1 KR102555447B1 KR1020177002619A KR20177002619A KR102555447B1 KR 102555447 B1 KR102555447 B1 KR 102555447B1 KR 1020177002619 A KR1020177002619 A KR 1020177002619A KR 20177002619 A KR20177002619 A KR 20177002619A KR 102555447 B1 KR102555447 B1 KR 102555447B1
- Authority
- KR
- South Korea
- Prior art keywords
- nucleic acid
- sequence
- transcript
- reference set
- artificial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 122
- 238000011002 quantification Methods 0.000 claims abstract description 33
- 108020004414 DNA Proteins 0.000 claims description 381
- 150000007523 nucleic acids Chemical class 0.000 claims description 222
- 108020004707 nucleic acids Proteins 0.000 claims description 220
- 102000039446 nucleic acids Human genes 0.000 claims description 220
- 239000000523 sample Substances 0.000 claims description 93
- 239000002773 nucleotide Substances 0.000 claims description 57
- 125000003729 nucleotide group Chemical group 0.000 claims description 57
- 238000012163 sequencing technique Methods 0.000 claims description 50
- 108700024394 Exon Proteins 0.000 claims description 32
- 238000013518 transcription Methods 0.000 claims description 32
- 230000035897 transcription Effects 0.000 claims description 32
- 230000000692 anti-sense effect Effects 0.000 claims description 31
- 238000005259 measurement Methods 0.000 claims description 31
- 239000003795 chemical substances by application Substances 0.000 claims description 28
- 108700005078 Synthetic Genes Proteins 0.000 claims description 26
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 claims description 24
- 230000000977 initiatory effect Effects 0.000 claims description 24
- 238000001514 detection method Methods 0.000 claims description 20
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 claims description 12
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 claims description 12
- 108020005067 RNA Splice Sites Proteins 0.000 claims description 12
- 229940029575 guanosine Drugs 0.000 claims description 12
- 239000012634 fragment Substances 0.000 claims description 9
- 150000003838 adenosines Chemical class 0.000 claims description 8
- 230000003278 mimic effect Effects 0.000 claims description 8
- 238000004445 quantitative analysis Methods 0.000 claims description 7
- 230000014759 maintenance of location Effects 0.000 claims description 6
- 238000003203 nucleic acid sequencing method Methods 0.000 claims description 5
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 4
- 108020004705 Codon Proteins 0.000 claims description 4
- 238000004364 calculation method Methods 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 108700009124 Transcription Initiation Site Proteins 0.000 claims description 3
- 230000005030 transcription termination Effects 0.000 claims description 3
- 108091033319 polynucleotide Proteins 0.000 abstract description 2
- 102000040430 polynucleotide Human genes 0.000 abstract description 2
- 108090000623 proteins and genes Proteins 0.000 description 77
- 239000000203 mixture Substances 0.000 description 34
- 241000282414 Homo sapiens Species 0.000 description 27
- 238000002360 preparation method Methods 0.000 description 25
- 238000007481 next generation sequencing Methods 0.000 description 24
- 238000003753 real-time PCR Methods 0.000 description 21
- 238000002474 experimental method Methods 0.000 description 19
- 238000013507 mapping Methods 0.000 description 14
- 238000003559 RNA-seq method Methods 0.000 description 13
- 230000008859 change Effects 0.000 description 13
- 238000009826 distribution Methods 0.000 description 13
- 230000014509 gene expression Effects 0.000 description 13
- 239000013612 plasmid Substances 0.000 description 13
- 239000013614 RNA sample Substances 0.000 description 12
- 238000004458 analytical method Methods 0.000 description 10
- 238000000746 purification Methods 0.000 description 10
- 108091027974 Mature messenger RNA Proteins 0.000 description 9
- 108091028043 Nucleic acid sequence Proteins 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- 230000001105 regulatory effect Effects 0.000 description 9
- 238000011156 evaluation Methods 0.000 description 8
- 239000002679 microRNA Substances 0.000 description 8
- 238000012545 processing Methods 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 108091092195 Intron Proteins 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- 210000004556 brain Anatomy 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 230000000295 complement effect Effects 0.000 description 7
- 238000010586 diagram Methods 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 108091070501 miRNA Proteins 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 230000003612 virological effect Effects 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- 238000003556 assay Methods 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 238000012937 correction Methods 0.000 description 6
- 238000000338 in vitro Methods 0.000 description 6
- 238000010208 microarray analysis Methods 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 230000002441 reversible effect Effects 0.000 description 5
- 239000003381 stabilizer Substances 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 230000002103 transcriptional effect Effects 0.000 description 5
- 241001515965 unidentified phage Species 0.000 description 5
- 108091026821 Artificial microRNA Proteins 0.000 description 4
- 102000053602 DNA Human genes 0.000 description 4
- 230000006820 DNA synthesis Effects 0.000 description 4
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 4
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 4
- 102000016911 Deoxyribonucleases Human genes 0.000 description 4
- 108010053770 Deoxyribonucleases Proteins 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- 108010029485 Protein Isoforms Proteins 0.000 description 4
- 102000001708 Protein Isoforms Human genes 0.000 description 4
- 101710137500 T7 RNA polymerase Proteins 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 239000011324 bead Substances 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 238000000546 chi-square test Methods 0.000 description 4
- 239000002299 complementary DNA Substances 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 238000002493 microarray Methods 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 230000008488 polyadenylation Effects 0.000 description 4
- 230000006641 stabilisation Effects 0.000 description 4
- 238000011105 stabilization Methods 0.000 description 4
- 230000001131 transforming effect Effects 0.000 description 4
- 238000009827 uniform distribution Methods 0.000 description 4
- 239000013598 vector Substances 0.000 description 4
- 108020005544 Antisense RNA Proteins 0.000 description 3
- 241000206602 Eukaryota Species 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 238000004590 computer program Methods 0.000 description 3
- 238000011157 data evaluation Methods 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000009396 hybridization Methods 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 238000010606 normalization Methods 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 2
- 108091026890 Coding region Proteins 0.000 description 2
- 108020003215 DNA Probes Proteins 0.000 description 2
- 239000003298 DNA probe Substances 0.000 description 2
- 238000001712 DNA sequencing Methods 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 102100038606 Death-associated protein kinase 3 Human genes 0.000 description 2
- 102100036498 Dual specificity testis-specific protein kinase 2 Human genes 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 2
- 102100039335 HAUS augmin-like complex subunit 5 Human genes 0.000 description 2
- 101000956149 Homo sapiens Death-associated protein kinase 3 Proteins 0.000 description 2
- 101000714156 Homo sapiens Dual specificity testis-specific protein kinase 2 Proteins 0.000 description 2
- 101001035821 Homo sapiens HAUS augmin-like complex subunit 5 Proteins 0.000 description 2
- 101001091379 Homo sapiens Kallikrein-5 Proteins 0.000 description 2
- 101001130147 Homo sapiens Probable D-lactate dehydrogenase, mitochondrial Proteins 0.000 description 2
- 101000671649 Homo sapiens Upstream stimulatory factor 2 Proteins 0.000 description 2
- 102100034868 Kallikrein-5 Human genes 0.000 description 2
- 108700011259 MicroRNAs Proteins 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 108700005081 Overlapping Genes Proteins 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 108700001094 Plant Genes Proteins 0.000 description 2
- 102100031708 Probable D-lactate dehydrogenase, mitochondrial Human genes 0.000 description 2
- 102000006382 Ribonucleases Human genes 0.000 description 2
- 108010083644 Ribonucleases Proteins 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 102100040103 Upstream stimulatory factor 2 Human genes 0.000 description 2
- 238000011481 absorbance measurement Methods 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 238000010804 cDNA synthesis Methods 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000000205 computational method Methods 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000009274 differential gene expression Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 2
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000037452 priming Effects 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 239000003161 ribonuclease inhibitor Substances 0.000 description 2
- 238000002864 sequence alignment Methods 0.000 description 2
- 210000001324 spliceosome Anatomy 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- AWPMRDJCWDOCSM-JXFKXHLWSA-N (2r,3s)-3-hydroxy-n-[11-[4-[4-[4-[11-[[2-[4-[(2r)-2-hydroxypropyl]triazol-1-yl]acetyl]amino]undecanoyl]piperazin-1-yl]-6-[2-[2-(2-prop-2-ynoxyethoxy)ethoxy]ethylamino]-1,3,5-triazin-2-yl]piperazin-1-yl]-11-oxoundecyl]-2-(4-methyltriazol-1-yl)butanamide Chemical compound N1=NC(C[C@H](O)C)=CN1CC(=O)NCCCCCCCCCCC(=O)N1CCN(C=2N=C(N=C(NCCOCCOCCOCC#C)N=2)N2CCN(CC2)C(=O)CCCCCCCCCCNC(=O)[C@@H]([C@H](C)O)N2N=NC(C)=C2)CC1 AWPMRDJCWDOCSM-JXFKXHLWSA-N 0.000 description 1
- FGRBYDKOBBBPOI-UHFFFAOYSA-N 10,10-dioxo-2-[4-(N-phenylanilino)phenyl]thioxanthen-9-one Chemical compound O=C1c2ccccc2S(=O)(=O)c2ccc(cc12)-c1ccc(cc1)N(c1ccccc1)c1ccccc1 FGRBYDKOBBBPOI-UHFFFAOYSA-N 0.000 description 1
- 108020004463 18S ribosomal RNA Proteins 0.000 description 1
- GNXFOGHNGIVQEH-UHFFFAOYSA-N 2-hydroxy-3-(2-methoxyphenoxy)propyl carbamate Chemical compound COC1=CC=CC=C1OCC(O)COC(N)=O GNXFOGHNGIVQEH-UHFFFAOYSA-N 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 241001501536 Alethe Species 0.000 description 1
- 108091093088 Amplicon Proteins 0.000 description 1
- 241000219195 Arabidopsis thaliana Species 0.000 description 1
- 108700020462 BRCA2 Proteins 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 101150008921 Brca2 gene Proteins 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 108090000994 Catalytic RNA Proteins 0.000 description 1
- 102000053642 Catalytic RNA Human genes 0.000 description 1
- 108091035707 Consensus sequence Proteins 0.000 description 1
- 102000001493 Cyclophilins Human genes 0.000 description 1
- 108010068682 Cyclophilins Proteins 0.000 description 1
- 238000000018 DNA microarray Methods 0.000 description 1
- 108060002716 Exonuclease Proteins 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 101000878605 Homo sapiens Low affinity immunoglobulin epsilon Fc receptor Proteins 0.000 description 1
- 101000595467 Homo sapiens T-complex protein 1 subunit gamma Proteins 0.000 description 1
- 101000655352 Homo sapiens Telomerase reverse transcriptase Proteins 0.000 description 1
- 238000009015 Human TaqMan MicroRNA Assay kit Methods 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 101710203526 Integrase Proteins 0.000 description 1
- 102100038007 Low affinity immunoglobulin epsilon Fc receptor Human genes 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001599018 Melanogaster Species 0.000 description 1
- 241000203407 Methanocaldococcus jannaschii Species 0.000 description 1
- 241000203353 Methanococcus Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 101100107522 Mus musculus Slc1a5 gene Proteins 0.000 description 1
- 101100202339 Mus musculus Slc6a13 gene Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 238000013381 RNA quantification Methods 0.000 description 1
- 101100202330 Rattus norvegicus Slc6a11 gene Proteins 0.000 description 1
- 101100273253 Rhizopus niveus RNAP gene Proteins 0.000 description 1
- 102000042773 Small Nucleolar RNA Human genes 0.000 description 1
- 108020003224 Small Nucleolar RNA Proteins 0.000 description 1
- 102100036049 T-complex protein 1 subunit gamma Human genes 0.000 description 1
- 108091023045 Untranslated Region Proteins 0.000 description 1
- 206010046865 Vaccinia virus infection Diseases 0.000 description 1
- 241000269457 Xenopus tropicalis Species 0.000 description 1
- 230000001594 aberrant effect Effects 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N adenyl group Chemical group N1=CN=C2N=CNC2=C1N GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 238000002306 biochemical method Methods 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 101150049515 bla gene Proteins 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 108091036078 conserved sequence Proteins 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 238000003936 denaturing gel electrophoresis Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000002681 effect on RNA Effects 0.000 description 1
- 101150097231 eg gene Proteins 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 102000013165 exonuclease Human genes 0.000 description 1
- 238000010195 expression analysis Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000013213 extrapolation Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000012165 high-throughput sequencing Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000000126 in silico method Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000009830 intercalation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 101150066555 lacZ gene Proteins 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 239000011807 nanoball Substances 0.000 description 1
- 208000025215 nuclear ribonucleic acid Diseases 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 125000005642 phosphothioate group Chemical group 0.000 description 1
- 238000005375 photometry Methods 0.000 description 1
- 102000028499 poly(A) binding Human genes 0.000 description 1
- 108091023021 poly(A) binding Proteins 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000012175 pyrosequencing Methods 0.000 description 1
- 238000011155 quantitative monitoring Methods 0.000 description 1
- 239000002096 quantum dot Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 108020004418 ribosomal RNA Proteins 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 108091092562 ribozyme Proteins 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000012536 storage buffer Substances 0.000 description 1
- 230000035892 strand transfer Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000002381 testicular Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000005026 transcription initiation Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000009966 trimming Methods 0.000 description 1
- 208000007089 vaccinia Diseases 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 238000012418 validation experiment Methods 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/682—Signal amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6846—Common amplification features
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2545/00—Reactions characterised by their quantitative nature
- C12Q2545/10—Reactions characterised by their quantitative nature the purpose being quantitative analysis
- C12Q2545/113—Reactions characterised by their quantitative nature the purpose being quantitative analysis with an external standard/control, i.e. control reaction is separated from the test/target reaction
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14176417.5 | 2014-07-09 | ||
| EP14176417 | 2014-07-09 | ||
| PCT/EP2015/065756 WO2016005524A1 (en) | 2014-07-09 | 2015-07-09 | Methods and products for quantifying rna transcript variants |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20170028383A KR20170028383A (ko) | 2017-03-13 |
| KR102555447B1 true KR102555447B1 (ko) | 2023-07-13 |
Family
ID=51224706
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020177002619A Active KR102555447B1 (ko) | 2014-07-09 | 2015-07-09 | Rna 전사물 변이체의 정량분석을 위한 방법 및 생성물 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US10513726B2 (enExample) |
| EP (1) | EP3167076B1 (enExample) |
| JP (3) | JP6930910B2 (enExample) |
| KR (1) | KR102555447B1 (enExample) |
| CN (1) | CN106471134B (enExample) |
| AU (1) | AU2015286672B2 (enExample) |
| CA (1) | CA2954495C (enExample) |
| DK (1) | DK3167076T3 (enExample) |
| LT (1) | LT3167076T (enExample) |
| WO (1) | WO2016005524A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2012307282B2 (en) | 2011-09-16 | 2018-03-15 | Lexogen Gmbh | Nucleic acid transcription method |
| AU2015286672B2 (en) | 2014-07-09 | 2021-12-02 | Lexogen Gmbh | Methods and products for quantifying RNA transcript variants |
| CN106771194B (zh) * | 2017-01-18 | 2018-07-20 | 青岛大学 | 一种检测病原微生物的方法 |
| US10828330B2 (en) * | 2017-02-22 | 2020-11-10 | IO Bioscience, Inc. | Nucleic acid constructs comprising gene editing multi-sites and uses thereof |
| CA3054307A1 (en) | 2017-02-22 | 2018-08-30 | Io Biosciences, Inc. | Nucleic acid constructs comprising gene editing multi-sites and uses thereof |
| SE541799C2 (en) * | 2018-04-11 | 2019-12-17 | David Yudovich | Determination of frequency distribution of nucleotide sequence variants |
| EP3781213A4 (en) | 2018-04-17 | 2022-10-19 | The Trustees of the University of Pennsylvania | TRANS-SPLICE MOLECULES |
| CN116219037A (zh) * | 2018-05-02 | 2023-06-06 | 宁夏农林科学院动物科学研究所 | 一种基于基因分型鉴定滩羊与非滩羊的方法 |
| EP3666904A1 (en) | 2018-12-14 | 2020-06-17 | Lexogen GmbH | Nucleic acid amplification and identification method |
| EP3901284A1 (en) * | 2020-04-20 | 2021-10-27 | BMBK Invest BV | Construct, kit and method for sample tracking |
| KR102690574B1 (ko) | 2020-06-26 | 2024-07-31 | 숙명여자대학교산학협력단 | 비타민 b1의 보호 및 전달을 위한 장용성 조성물 |
| KR102690573B1 (ko) | 2020-06-26 | 2024-07-31 | 숙명여자대학교산학협력단 | 사이클로덱스트린을 이용한 경구투여용 복합 조성물 및 이의 제조방법 |
| WO2023086441A1 (en) * | 2021-11-12 | 2023-05-19 | Regents Of The University Of Minnesota | Compositions and methods for transcriptional activation |
| EP4438741A4 (en) * | 2021-11-26 | 2025-08-06 | Daan Gene Co Ltd | HIGH-THROUGHPUT SEQUENCING METHOD BASED ON THE INTERNAL REFERENCE OF A KNOWN MARKER |
| CA3252043A1 (en) * | 2022-05-13 | 2023-11-16 | Ascidian Therapeutics, Inc. | ABCA4 TRANS-SPLICING MOLECULES |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020110828A1 (en) | 2001-01-12 | 2002-08-15 | Ferea Tracy L. | Methods and compositions for microarray control |
| US20070072189A1 (en) | 2004-03-11 | 2007-03-29 | The Government Of The United States Of America As | Artificial mutation controls for diagnostic testing |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2593343B1 (fr) | 1986-01-20 | 1988-03-25 | Thomson Csf | Matrice d'elements photosensibles et son procede de fabrication, procede de lecture associe, et application de cette matrice a la prise de vue d'images |
| EP1386009A4 (en) | 2001-05-07 | 2005-04-27 | Amersham Biosciences Corp | CONSTRUCTION OF ARTIFICIAL GENES FOR USE AS CONTROLS IN GENE EXPRESSION ANALYSIS SYSTEMS |
| US20040009512A1 (en) | 2002-05-02 | 2004-01-15 | Manuel Ares | Arrays for detection of products of mRNA splicing |
| EP2333104A1 (en) * | 2009-12-11 | 2011-06-15 | Lexogen GmbH | RNA analytics method |
| AU2015286672B2 (en) | 2014-07-09 | 2021-12-02 | Lexogen Gmbh | Methods and products for quantifying RNA transcript variants |
-
2015
- 2015-07-09 AU AU2015286672A patent/AU2015286672B2/en active Active
- 2015-07-09 US US15/323,951 patent/US10513726B2/en active Active
- 2015-07-09 JP JP2017501008A patent/JP6930910B2/ja active Active
- 2015-07-09 DK DK15736490.2T patent/DK3167076T3/da active
- 2015-07-09 EP EP15736490.2A patent/EP3167076B1/en active Active
- 2015-07-09 CA CA2954495A patent/CA2954495C/en active Active
- 2015-07-09 KR KR1020177002619A patent/KR102555447B1/ko active Active
- 2015-07-09 LT LTEPPCT/EP2015/065756T patent/LT3167076T/lt unknown
- 2015-07-09 CN CN201580035408.5A patent/CN106471134B/zh active Active
- 2015-07-09 WO PCT/EP2015/065756 patent/WO2016005524A1/en not_active Ceased
-
2019
- 2019-10-03 JP JP2019182851A patent/JP2020014478A/ja active Pending
-
2021
- 2021-06-01 JP JP2021092115A patent/JP7568581B2/ja active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020110828A1 (en) | 2001-01-12 | 2002-08-15 | Ferea Tracy L. | Methods and compositions for microarray control |
| US20070072189A1 (en) | 2004-03-11 | 2007-03-29 | The Government Of The United States Of America As | Artificial mutation controls for diagnostic testing |
Non-Patent Citations (1)
| Title |
|---|
| Genome Res. 2011 Sep; 21(9): 1543-1551 |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20170028383A (ko) | 2017-03-13 |
| JP2017525341A (ja) | 2017-09-07 |
| DK3167076T3 (da) | 2022-02-21 |
| US10513726B2 (en) | 2019-12-24 |
| WO2016005524A1 (en) | 2016-01-14 |
| AU2015286672A1 (en) | 2016-12-15 |
| JP2020014478A (ja) | 2020-01-30 |
| JP2021153588A (ja) | 2021-10-07 |
| HK1231518A1 (zh) | 2017-12-22 |
| EP3167076A1 (en) | 2017-05-17 |
| JP7568581B2 (ja) | 2024-10-16 |
| CA2954495C (en) | 2024-03-05 |
| CN106471134A (zh) | 2017-03-01 |
| US20170321248A1 (en) | 2017-11-09 |
| CN106471134B (zh) | 2021-11-12 |
| LT3167076T (lt) | 2022-02-10 |
| EP3167076B1 (en) | 2021-11-17 |
| JP6930910B2 (ja) | 2021-09-01 |
| CA2954495A1 (en) | 2016-01-14 |
| AU2015286672B2 (en) | 2021-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102555447B1 (ko) | Rna 전사물 변이체의 정량분석을 위한 방법 및 생성물 | |
| AU2022203184B2 (en) | Sequencing controls | |
| AU2020223681B2 (en) | Plant regulatory elements and uses thereof | |
| KR20230053735A (ko) | 게놈의 조정을 위한 개선된 방법 및 조성물 | |
| CN104024438B (zh) | Snp位点集合及其使用方法与应用 | |
| KR20200020903A (ko) | 핵산 가이드 뉴클레아제 | |
| KR20210018219A (ko) | 발효 및 생산 중 곰팡이 형태를 제어하기 위한 신호 전달에 포함된 유전자의 조작 | |
| CN106471008B (zh) | 棕榈Mantle表型检测 | |
| KR20080096495A (ko) | 소과 동물에서 배최장근 최대력, 근내 지방, 식용우소매유통 생산량 및 순 사료 섭취량으로부터 선택된 형질을평가하는 방법 | |
| AU2008200749B2 (en) | Promoters for regulation of plant gene expression | |
| KR102510442B1 (ko) | 극미량 중증열성혈소판감소증후군 바이러스, 아데노 바이러스 및 신종코로나 바이러스 검출용 프로브 세트, 이를 이용한 중증열성혈소판감소증후군 바이러스, 아데노 바이러스 및 신종코로나 바이러스의 전장 유전체 서열 분석 및 검출 방법 | |
| CN114032298B (zh) | 用于检测遗传性胆红素代谢异常及肝内胆汁淤积症相关基因变异的探针组、试剂盒及其应用 | |
| KR102458471B1 (ko) | Snp를 검출 또는 증폭할 수 있는 제제를 포함하는 소의 도체중 판별용 조성물 및 이를 포함하는 키트 | |
| KR20240019766A (ko) | 인터페론 유도 헬리카제 c 도메인 1(ifih1) 억제제를 이용한 건선의 치료 | |
| HK1231518B (zh) | 用於定量 rna 转录物变体的方法和产物 | |
| KR20230079107A (ko) | 개선된 특성을 갖는 유전자 변형된 메틸로바실러스 세균 | |
| KR102458466B1 (ko) | Snp를 검출 또는 증폭할 수 있는 제제를 포함하는 소의 등지방두께 판별용 조성물 및 이를 포함하는 키트 | |
| KR102894377B1 (ko) | 한국인 친족 관계 확인을 위한 918개의 snp 패널 및 이의 용도 | |
| KR102480121B1 (ko) | 수면병 저항성 소 African taurine cattle (AFT) 품종 특이적 단일염기다형성 및 그의 용도 | |
| TWI902763B (zh) | 基於重組痘病毒之抗SARS-CoV-2病毒疫苗 | |
| CN113403404B (zh) | 一种circRNA、产品及其应用 | |
| CN115966258A (zh) | 基于莱文斯坦距离筛选ires的方法及其筛选的多核苷酸 | |
| KR20230158917A (ko) | 한국인 친족 관계 확인을 위한 482개의 snp 패널 및 이의 용도 | |
| CN116648513A (zh) | 切酶样敲除植物细胞 | |
| JPH07123984A (ja) | 特異的メッセンジャーrnaを検出・測定するためのプライマー |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20170126 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20200622 Comment text: Request for Examination of Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20220303 Patent event code: PE09021S01D |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20220930 Patent event code: PE09021S01D |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20230623 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20230710 Patent event code: PR07011E01D |
|
| PR1002 | Payment of registration fee |
Payment date: 20230711 End annual number: 3 Start annual number: 1 |
|
| PG1601 | Publication of registration |